Radiotherapy With Pembrolizumab in Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Clinical trial NCT03386357 · TERMINATED
Trial details
- NCT number
- NCT03386357
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-20
- Primary completion
- 2024-10-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.